Skip to Main Content
Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment
  6. Aspirin

Aspirin

  • Angina (16)
  • Antithrombotics (417)
    • Drug-Induced Thrombosis (37)
    • Prevention (51)
    • Reversal (25)
    • Treatment (376)
      • Apixaban (Eliquis) (103)
      • Aspirin (194)
      • Cangrelor (Kengreal) (2)
      • Clopidogrel (Plavix) (126)
      • Dabigatran (Pradaxa) (113)
      • Edoxaban (Savaysa) (30)
      • Low Molecular Weight Heparins (78)
      • Other (62)
      • Prasugrel (Effient) (55)
      • Rivaroxaban (Xarelto) (115)
      • Ticagrelor (Brilinta) (44)
      • Vorapaxar (Zontivity) (3)
      • Warfarin - Drug Interactions (37)
      • Warfarin - Treatment (173)
  • Arrhythmias (187)
  • Blood Pressure (38)
  • Cardiovascular Disease and Depression (10)
  • Cholesterol (61)
  • Dyslipidemia (318)
  • Endocarditis (22)
  • Heart Disease (97)
  • Heart Failure (224)
  • Hypertension (351)
  • Hypotension (24)
  • Ischemic Heart Disease/Acute Coronary Syndromes (406)
  • Myocardial Infarction (53)
  • Peripheral Vascular Disease (9)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (1)
  • Resources (1040)
  • Stroke (193)
31 - 45 of 194 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Optimize Anticoagulants to Reduce Stroke Risk in Atrial Fib Patients March 2019
Article: Expect to See TWO Antiplatelets Short-Term After a Minor Stroke or TIA March 2019
Patient Education: What You Need to Know About A Fib February 2019
Chart: Bridging Warfarin February 2019
Article: Don't Suggest Xarelto for Most Coronary or Peripheral Artery Disease Patients December 2018
PL Voices: Antithrombotics for Stable Coronary Artery Disease or Peripheral Artery Disease December 2018
Chart: Common Cardiovascular Risk Calculators September 2018
Article: Optimize Meds to Reduce Recurrent Stroke Risk July 2018
Article: Put the Aspirin and NSAID Interaction in Perspective July 2018
PL Voices: NSAID Impact on Cardiovascular Benefits of Low-Dose Aspirin July 2018
Patient Education: Aspirin and Your Heart July 2018
Article: Think of Antiplatelets for Arterial Clots and Anticoagulants for Venous Clots June 2018
Chart: Oral Anticoagulants for A Fib June 2018
Article: Expect to See Aspirin Used More to Prevent VTE After Hip or Knee Replacement May 2018
PL Voices: VTE Prophylaxis After Hip or Knee Replacement May 2018
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved